| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.5M | +47.3% | +151.4% |
| Cost of Revenue | $608K | +15.8% | +69.8% |
| Gross Profit | $883K | +81.3% | +275.7% |
| R&D Expense | $167K | +3.1% | -68.3% |
| SG&A Expense | $3.5M | +9.3% | +4.3% |
| Operating Income | -$2.8M | +3.3% | +23.9% |
| Net Income | -$2.8M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $6.0M | +42.8% | +22.6% |
| Accounts Receivable | $1.8M | +101.1% | +134.2% |
| Inventory | $5.5M | -7.5% | -13.5% |
| Current Assets | $13.6M | +20.0% | +10.9% |
| Total Assets | $18.2M | +16.8% | -2.9% |
| Current Liabilities |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$7.6M | — | — |
| Capital Expenditures | $93K | — | — |
| Investing Cash Flow | -$249K | — | — |
| Financing Cash Flow | $10.2M | — | — |
| Free Cash Flow | -$7.7M | — | — |
| +25.6% |
| -239.3% |
| EPS (Basic) | -$0.06 | +14.3% | -250.0% |
| EPS (Diluted) | -$0.06 | +14.3% | -250.0% |
| $1.9M |
| -4.7% |
| -82.1% |
| Total Liabilities | $4.1M | +6.8% | -66.8% |
| Stockholders' Equity | $14.1M | +20.1% | +120.5% |